(84) designed tumor-targeting lipid dendrimeric calcium phosphate (TT-LDCP) nanoparticles (NPs) using thymitine-functionalized dendrimeric polymers to efficiently deliver siRNA and pDNA into HCC cells, increase tumor invasion and CD8 T cell activation, and enhance the efficacy of cancer vaccines. The gene discussed is CD8A; the disease is neoplasm.